Two new isoflavonoids have been isolated from the aerial parts of Colutea istria Lam. of Egyptian origin and identified as (3R)-7-hydroxy-3´,4´-dimethoxyisoflavan-2´,5´-quinone (1) and 6,3´-dihydroxy-7,4´-dimethoxyisoflavone (2). Their structures were determined by various 1D and 2D NMR spectroscopic techniques. The antibacterial, antifungal, antimalarial and cytotoxic activities of 1 and 2 were evaluated. Compound 1 displayed selective antimicrobial activity against Methicillinresistant Staphylococcus aureus with an IC 50 value of 20 μg/mL.
The genus Colutea (Fabaceae) includes 28 species found mainly in northeast and east Africa, mostly in dry mountains [1] . C. istria Lam. is the only species recorded in Sinai, Egypt [1, 2] . In previous phytochemical studies of Colutea species [3] [4] [5] , a number of flavonoids were isolated, some of which showed antibacterial, antifungal [3] [4] [5] and cytotoxic [3] activities. In this present work we describe the isolation and structure elucidation of two new isoflavonoids, 1 and 2, from C. istria of Egyptian origin, as well as reporting their antimicrobial, antimalarial and cytotoxic activities.
Compound 1 was isolated as an optically active, orange, amorphous powder. Its molecular formula was deduced from the HR-ESI-MS ion at m/z 339.0866 [M+Na] + as C 17 H 16 O 6 . The 13 C NMR, DEPT and HMQC spectra displayed the presence of 17 resonances, including two OCH 3 , two CH 2 , four aromatic CH, one aliphatic CH, and eight fully substituted carbons. The UV absorption bands at λ max 215 and 265 nm were suggestive of an isoflavan skeleton [6] , which was confirmed by the 13 C NMR and DEPT-135 resonances ( Table 1 ) at δ C 68.3 (C-2, CH 2 ), 31.0 (C-3, CH) and 29.1 (C-4, CH 2 ) [7] . The 1 H NMR and COSY spectra of 1 (Table 1 ) showed an ABX system of ring A [an ortho-coupled doublet at δ H 6.87 (J = 8.0 Hz), an ortho-and metacoupled double doublet at δ H 6.40 (J = 2.0, 8.0 Hz) and a meta-coupled signal at δ H 6.31 (J = 2.0 Hz)].
The 1 H NMR spectrum also showed two methoxy groups at δ H 3.98 and 3.99 and one isolated aromatic proton at δ H 6.35 (s, H-6´). In the UV spectrum the 6 nm bathochromic shift exhibited with the addition of NaOAc to the methanolic solution of 1 suggested the presence of a free hydroxyl group at C-7 of ring A [6] . The 13 C NMR spectrum showed the presence of two carbonyl carbons at δ C 183.8 and 184.4 characteristic of isoflavanoquinones [4, 5, 7] . locations at C-3´ and C-4´ ( Figure 1 ). The NMR data of 1 was quite similar to those reported for (3R)-colutequinone isolated from C. arborescens [5] except for the absence of the C-7 methoxy group and the presence of a hydroxyl group instead. The CD spectrum of 1 exhibited a positive Cotton effect at λ max 270 nm indicating the 3R configuration [4, 5, 8, 9] . Thus compound 1 was identified as (3R)-7hydroxy-3´,4´-dimethoxyisoflavan-2´,5´-quinone. [6, 7] . The substitution pattern of ring A and ring B was determined by the analysis of coupling constants, and COSY, HMQC and HMBC experiments (Figure 2) . The 1 H NMR spectrum of 2 showed signals for an ABX system for ring B at A sharp singlet at δ H 7.93, which showed HMBC correlation with the signal due to the carbonyl carbon (δ C 175.9, C-4), was assigned to H-5, while another singlet at δ H 7.24 was attributed to H-8, and the other methoxy group was placed at position 7 on the basis of HMBC correlation (Figure 2) and 2 did not show any antimalarial activity. Ciprofloxacin (IC 50 0.1 µg/mL) and chloroquine [IC 50 9.0 ng/mL (D6 clone) and 130 ng/mL (W2 clone)] were used as positive controls for anti-MRSA and antimalarial assays respectively. In addition, neither of the compounds showed toxicity to Vero cells (monkey kidney fibroblast) at concentrations up to 25 µg/mL [11] . The cytotoxic agent, doxorubicin was used as positive control.
Experimental
General: Optical rotations were taken on a Perkin-Elmer 241 polarimeter. UV spectra were recorded on a Hewlett-Packard 8435 spectrometer. The CD spectrum was recorded on a Jasco DIP-370 spectropolarimeter. IR spectra were measured on a MIDAC M-series FTIR instrument. 1D ( 1 H, 13 C and DEPT-135) and 2D (g COSY, gHSQC, and gHMBC) NMR spectra were recorded on a Varian Inova spectrometer using standard Varian pulse sequence programs. The HR-ESI-MS were obtained on a Brucker BioApex FT mass spectrometer. HPLC utilized a Shimadzu LC-10AT instrument with an ODS C-18 column (250 x 10 mm). TLC was performed on sheets precoated with silica gel 60 F 254 (Merck, Germany) using CHCl 3 /MeOH (19:1). Compounds were detected by spraying with 1% vanillin in H 2 SO 4 -EtOH (4:1), followed by heating. 
Extraction and isolation:
The air dried, powdered C. istria (800 g) were extracted with EtOH: H 2 O (8:2, 4 L) by maceration at room temp. The ethanolic extract was concentrated under reduced pressure to yield 60 g of crude extract, which was dissolved in CH 3 OH:H 2 O (1:1, 500 mL) and extracted successively with n-hexane (500 mL x 3), CH 2 Cl 2 (500 mL x 3) and n-butanol (500 mL x 2). The CH 2 Cl 2 extract (13 g) was fractionated on a MCI gel column (200 g) eluting with MeOH-H 2 O (70:30) to yield 12 fractions (A-L). Fraction B (2.0 g) was chromatographed on a silica gel column (60 g) using CH 2 Cl 2 -MeOH (98:2) to give 8 subfractions (B 1 -B 8 ). Subfraction B 2 (36.2 mg) was subjected to C18 HPLC using CH 3 OH-H 2 O (7:3) as mobile phase to afford 1 (13.2 mg, R t = 7.2 min). Subfraction B 3 (285 mg) was purified on an SPE-C18 column (5.0 g) eluted with a mixture of CH 3 CN-H 2 O (60:40) to give 2 (7 mg).
